Pharmacokinetic Models: Comparison and Selection Criterion
Structure-Activity Relationships and Drug Design
Quantitative Aspects of Drug-Receptor Interaction
Data Validation
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 22, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Partha Pratim Roy1, Somnath Paul, Indrani Mitra
1Department of Pharmaceutical Technology, Division of Medicinal and Pharmaceutical Chemistry, Drug Theoretics and Cheminformatics Lab, Jadavpur University, Kolkata, India. partha_chemju@yahoo.co.in
New validation parameters, r(m)(2) and R(p)(2), offer a stricter assessment for quantitative structure-activity relationship (QSAR) models. These novel metrics supplement traditional validation, ensuring more reliable predictive models, especially for regulatory decisions.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: